文献速递艾滋病与性传播感染

抗逆转录病毒治疗启动后脂肪因子、体重增加与代谢炎症标志物的关系

Adipokines, Weight Gain and Metabolic and Inflammatory Markers After Antiretroviral Therapy Initiation: AIDS Clinical Trials Group (ACTG) A5260s.
PubMed 文献 · Clin Infect Dis · 2022-01-01

瘦素平均升高22%,脂联素无变化;瘦素是HOMA-IR和hsCRP的更强决定因素,且独立于脂肪体积。

要点

  • 初治HIV感染者启动ART后96周内瘦素平均升高22%,脂联素无显著变化。
  • 瘦素水平较脂肪体积更能预测HOMA-IR和hsCRP升高。
  • 脂肪体积增加与胰岛素抵抗和炎症相关,但瘦素介导部分效应。

核心结论

  • 循环瘦素升高与HOMA-IR和hsCRP升高相关,且独立于脂肪体积。
  • 脂肪细胞脂质含量增加可能 contribuir 至糖耐量受损和全身炎症。

研究设计与样本

  • ACTG A5260s代谢子研究,嵌套于A5257随机试验。
  • 使用双能X线吸收法和腹部CT测量脂肪分布。
  • 测量血清瘦素、脂联素、HOMA-IR和hsCRP。

主要发现

  • 瘦素平均变化22%,脂联素平均变化1%,组间无差异。
  • 躯干、肢体、腹部皮下和内脏脂肪增加与HOMA-IR和hsCRP升高相关。
  • 中介模型显示瘦素是HOMA-IR和hsCRP的更强决定因素。
  • 脂联素未观察到类似中介效应。

临床怎么用

  • 启动ART后应关注瘦素水平变化,其与胰岛素抵抗和炎症相关。
  • 瘦素可能作为代谢并发症的预测标志物,独立于脂肪体积。

局限性

  • 样本以男性为主(90%),黑种人占29%,中位年龄36岁,外推需谨慎。
  • 观察性研究,不能确定因果关系。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND: The adipokines leptin and adiponectin, produced primarily by adipose tissue, have diverse endocrine and immunologic effects, and circulating levels reflect adipocyte lipid content, local inflammation, and tissue composition. We assessed relationships between changes in regional fat depots, leptin and adiponectin levels, and metabolic and inflammatory markers over 96 weeks in the AIDS Clinical Trials Group (ACTG) A5260s metabolic substudy of the A5257 randomized trial of tenofovir disoproxil fumarate/emtricitabine plus atazanavir/ritonavir, darunavir/ritonavir, or raltegravir among treatment-naive persons with human immunodeficiency virus (PWH). METHODS: Fat depots were measured using dual-energy absorptiometry and abdominal computed tomographic imaging at treatment initiation and 96 weeks later. Serum leptin and adiponectin, homeostatic model assessment of insulin resistance (HOMA-IR), and high-sensitivity C-reactive protein (hsCRP) were measured at the same timepoints. Multivariable regression models assessed relationships between fat depots, adipokines, HOMA-IR, and hsCRP at week 96. RESULTS: Two hundred thirty-four participants maintained viral suppression through 96 weeks (90% male, 29% black, median age 36 years). Serum leptin increased over 96 weeks (mean change 22%) while adiponectin did not (mean change 1%), which did not differ by study arm. Greater trunk, limb, and abdominal subcutaneous and visceral fat were associated with higher HOMA-IR and hsCRP at 96 weeks, but serum leptin level was a stronger determinant of these endpoints using a mediation model approach. A similar mediating effect was not observed for adiponectin. CONCLUSIONS: Higher circulating leptin is associated with greater HOMA-IR and hsCRP independent of fat depot size, suggesting that greater adipocyte lipid content may contribute to impaired glucose tolerance and systemic inflammation among PWH starting antiretroviral therapy.

来源:Clin Infect Dis,查看原文。版权归原作者所有。

引用

  1. Koethe JR, Moser C, Brown TT, et al. Adipokines, Weight Gain and Metabolic and Inflammatory Markers After Antiretroviral Therapy Initiation: AIDS Clinical Trials Group (ACTG) A5260s. Clin Infect Dis. 2022. PMID: 34117756. doi:10.1093/cid/ciab542

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。